TyraTech, Inc. Statement Re New Distribution Agreement (7961P)
23 February 2016 - 6:00PM
UK Regulatory
TIDMTYR TIDMTYRU
RNS Number : 7961P
TyraTech, Inc.
23 February 2016
For release at 07.00: 23 February 2016
TyraTech, Inc.
("TyraTech" or the "Company")
New Distribution Agreement with major US retailer: Rite Aid
TyraTech, Inc. (AIM: TYR and TYRU), a life sciences technology
company focused on nature-derived insect and parasite control
products, announces a new distribution agreement for its award
winning head lice treatment Vamousse(R) with major US retailer Rite
Aid Corporation ("Rite Aid").
Rite Aid is a Fortune 500 company and drugstore chain in the
United States with over 4,500 stores nationwide. With the addition
of Rite Aid, Vamousse is now available in all of the top four
retail pharmacy chains in the US and nationwide can be found in a
total of over 24,000 individual stores, including Walmart,
Walgreens, and CVS Health.
TyraTech has also made progress in increasing Vamousse's UK
presence having increased its store presence in Tesco and
Sainsbury's to achieve coverage of more than 7,800 retail
stores.
Bruno Jactel, Chief Executive Officer, said: "We recognize that
the purchase of head lice treatment is for almost all parents and
caregivers an emergency buy. When a child is identified with a lice
infestation, you want to find a resolution immediately. For this
reason, achieving strong and comprehensive distribution in our
major target markets is paramount. Our strategy has been to make
sure that the consumer can find our product in whatever store is
closest to home and then to drive brand awareness through our
marketing programs. Broad distribution helps us achieve the best
return on investment for our marketing spend.
"We continue to build on the success of establishing the
Vamousse head lice franchise and monetizing our technology. These
additional distribution agreements across major retailers in both
the US and UK are strong validation for the value and efficacy of
our products for consumers and retailers alike."
*-ends*-
For further information please visit: www.tyratech.com or
contact:
TyraTech Inc. Tel: +1 919 415 4340
Bruno Jactel, Chief Executive Officer Tel: +1 919 415 4287
Erica H. Boisvert, Chief Financial Officer
SPARK Advisory Partners Limited, Nominated Adviser Tel: +44 203 368 3551
Matt Davis / Mark Brady
Allenby Capital Limited, Joint Broker Tel: +44 20 3328 5656
Chris Crawford
Whitman Howard Limited, Joint Broker Tel: +44 20 7659 1234
Ranald McGregor-Smith/ Niall Devins
Belvedere Communications (PR) Tel: +44 20 3567 0510
John West / Kim van Beeck:
This information is provided by RNS
The company news service from the London Stock Exchange
END
STRSESFWEFMSEEE
(END) Dow Jones Newswires
February 23, 2016 02:00 ET (07:00 GMT)
Tyratech (DI) (LSE:TYRU)
Historical Stock Chart
From Jun 2024 to Jul 2024
Tyratech (DI) (LSE:TYRU)
Historical Stock Chart
From Jul 2023 to Jul 2024